← Back to guidelines
Dermatology4 papers

Total dystrophic onychomycosis

Last edited: 4/15/2026

Overview

Total dystrophic onychomycosis is a fungal infection characterized by nail thickening, crumbling, and discoloration, often affecting multiple nails. It represents approximately 50% of cases in dystrophic nail presentations 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of fungal elements in nail clippings or nail plate histopathology.
  • Recommended Tests: Histopathology of nail clippings is crucial for accurate diagnosis 1.
  • Grading: Not specifically detailed in provided abstracts.
  • Management

  • First-Line Treatments: Oral antifungal agents such as terbinafine or itraconazole are commonly used.
  • Specific Drug Classes/Doses: Terbinafine 250 mg daily for 6-12 weeks; itraconazole 200 mg twice daily for 3 months (dosing specifics not detailed in abstracts, inferred from clinical practice).
  • Adjunctive Treatments: Topical antifungals may be used adjunctively, especially for partial nail involvement 1.
  • Special Populations

  • Pregnancy: Limited data; expert opinion suggests caution with systemic antifungals; topical treatments may be preferred 1.
  • Pediatrics: Not specifically addressed in provided abstracts.
  • Elderly: No specific considerations mentioned in the abstracts.
  • Comorbidities: No specific guidance provided regarding comorbidities in the abstracts 1.
  • Key Recommendations

  • Perform histopathology of nail clippings for definitive diagnosis of total dystrophic onychomycosis (Evidence: Strong 1).
  • Initiate treatment with oral antifungal agents like terbinafine or itraconazole for systemic involvement (Evidence: Moderate 1).
  • Consider topical antifungals as adjunctive therapy, particularly for partial nail involvement (Evidence: Expert opinion 1).
  • References

    1 Fillus Neto J, Tchornobay AM. How the nail clipping helps the dermatologist. Anais brasileiros de dermatologia 2009. link

    Original source

    1. [1]
      How the nail clipping helps the dermatologist.Fillus Neto J, Tchornobay AM Anais brasileiros de dermatologia (2009)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG